Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

An in Vitro Model of Differentiation of Memory B Cells Into Plasmablasts and Plasma Cells Including Detailed Phenotypic and Molecular Characterization.

Michel Jourdan, Anouk Caraux, John De Vos, PhD, Geneviève Fiol, Marion Larroque, Chantal Cognot, Caroline Bret, Christophe Duperray, Dirk Hose, Bernard Klein

Blood (2009) 114 (22): 1636.

https://doi.org/10.1182/blood.V114.22.1636.1636

Published: 2009

Journal Articles

Osteoclast Gene Expression Profiling in Multiple Myeloma

Jerome Moreaux, Dirk Hose, Thierry Rème, Philippe Moine, Karène Mahtouk, Marion Moos, Guilhem Requirand, John De Vos, PhD, Jean François Rossi, Hartmut Goldschmidt, Bernard Klein

Blood (2008) 112 (11): 2735.

https://doi.org/10.1182/blood.V112.11.2735.2735

Published: 2008

Journal Articles

The Clinical Utility of Microarray-Based Gene Expression Profiling in the Diagnosis and Sub-Classification of Leukemia: Final Report on 3252 Cases from the International MILE Study Group

Blood (2008) 112 (11): 753.

https://doi.org/10.1182/blood.V112.11.753.753

Published: 2008

Journal Articles

Gene Expression Profiling and Real-Time PCR Analyses Make It Possible To Identify Novel Potential Cancer-Testis Antigens in Multiple Myeloma.

Maud Condomines, PhD, Dirk Hose, PhD, MD, Thierry Reme, PhD, John de Vos, PhD, MD, Guilhem Requirand, Jean-Francois Rossi, PhD, MD, Hartmunt Goldschmidt, PhD, MD, Bernard Klein

Blood (2007) 110 (11): 1793.

https://doi.org/10.1182/blood.V110.11.1793.1793

Published: 2007

Journal Articles

An International Multi-Center Study To Define the Application of Microarray-Based Gene Expression Profiling in the Diagnosis and Sub-Classification of Leukemia (MILE Study): Analysis of Completed Stage I with 2030 Patients Achieved a 95.4% Accuracy.

Blood (2007) 110 (11): 3169.

https://doi.org/10.1182/blood.V110.11.3169.3169

Published: 2007

Journal Articles

An International Multi-Center Study To Define the Application of Microarrays in the Diagnosis and Subclassification of Leukemia (MILE Study): Interim Analysis Based on 1,889 Patients Achieves 95.4% Prediction Accuracy.

Blood (2006) 108 (11): 103.

https://doi.org/10.1182/blood.V108.11.103.103

Published: 2006

Journal Articles

A Multi-Center and Multi-National Program To Assess the Clinical Accuracy of the Molecular Subclassification of Leukemia by Gene Expression Profiling.

Torsten Haferlach, MD, Alexander Kohlmann, PhD, Guiseppe Basso, PhD, Marie-Christine Bene, PhD, James R. Downing, PhD, Jesus M. Hernandez, MD, Wolf-Karsten Hofmann, MD, Thomas J. Kipps, PhD, Truus te Kronnie, PhD, Wei-Min Liu, Sunhee Ro, Elisabeth MacIntyre, PhD, Ken I. Mills, PhD, Claude Preudhomme, PhD, Laura Z. Rassenti, PhD, John de Vos, PhD, Mickey Williams, PhD, Lothar Wieczorek, Robin Foa, PhD

Blood (2005) 106 (11): 757.

https://doi.org/10.1182/blood.V106.11.757.757

Published: 2005

NARROW

An in Vitro Model of Differentiation of Memory B Cells Into Plasmablasts and Plasma Cells Including Detailed Phenotypic and Molecular Characterization.

Osteoclast Gene Expression Profiling in Multiple Myeloma

The Clinical Utility of Microarray-Based Gene Expression Profiling in the Diagnosis and Sub-Classification of Leukemia: Final Report on 3252 Cases from the International MILE Study Group

Gene Expression Profiling and Real-Time PCR Analyses Make It Possible To Identify Novel Potential Cancer-Testis Antigens in Multiple Myeloma.

An International Multi-Center Study To Define the Application of Microarray-Based Gene Expression Profiling in the Diagnosis and Sub-Classification of Leukemia (MILE Study): Analysis of Completed Stage I with 2030 Patients Achieved a 95.4% Accuracy.

An International Multi-Center Study To Define the Application of Microarrays in the Diagnosis and Subclassification of Leukemia (MILE Study): Interim Analysis Based on 1,889 Patients Achieves 95.4% Prediction Accuracy.

A Multi-Center and Multi-National Program To Assess the Clinical Accuracy of the Molecular Subclassification of Leukemia by Gene Expression Profiling.

Email alerts

ASH Publications

American Society of Hematology

An in Vitro Model of Differentiation of Memory B Cells Into Plasmablasts and Plasma Cells Including Detailed Phenotypic and Molecular Characterization.

Osteoclast Gene Expression Profiling in Multiple Myeloma

The Clinical Utility of Microarray-Based Gene Expression Profiling in the Diagnosis and Sub-Classification of Leukemia: Final Report on 3252 Cases from the International MILE Study Group

Gene Expression Profiling and Real-Time PCR Analyses Make It Possible To Identify Novel Potential Cancer-Testis Antigens in Multiple Myeloma.

An International Multi-Center Study To Define the Application of Microarray-Based Gene Expression Profiling in the Diagnosis and Sub-Classification of Leukemia (MILE Study): Analysis of Completed Stage I with 2030 Patients Achieved a 95.4% Accuracy.

An International Multi-Center Study To Define the Application of Microarrays in the Diagnosis and Subclassification of Leukemia (MILE Study): Interim Analysis Based on 1,889 Patients Achieves 95.4% Prediction Accuracy.

A Multi-Center and Multi-National Program To Assess the Clinical Accuracy of the Molecular Subclassification of Leukemia by Gene Expression Profiling.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only